Important Changes in UK Law on Reproductive and Genetic Technologies
By David King,
Genetic Crossroads
| 01. 26. 2007
Editor's note:
Many consider the UK approach to human biotechnologies to be a model of comprehensive and responsible policy. Since its creation in 1990, a government agency called the Human Fertilisation and Embryology Authority (HFEA) has set and enforced regulations for assisted reproductive technology and research involving human embryos. Observers often contrast this situation to the "Wild West" in the United States, where regulation and public oversight of these technologies are minimal.
Here, Dr. David King gives his views on government proposals that would reorganize the HFEA and set important new rules. King is a former molecular biologist and director of Human Genetics Alert, an independent watchdog group based in London.
By David King, PhD
In December, the UK government published a set of proposals that would reform the Human Fertilization and Embryology Act. The legislation dates from 1990; in recent years scientific developments and changes in social attitudes have made it increasingly outdated.
The government's proposals follow a public consultation on the law in 2005, and precede publication later this year of draft legislation, which will be scrutinized...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...